Post-Purdue Pharma Cases: What’s Next?

Rob Feinstein will be speaking at this year’s TMA Annual in New Orleans on October 16, 2025. His panel, entitled “Post-Purdue Pharma Cases: What’s Next?”, will take a deep dive into how courts have interpreted Purdue Pharma’s reach on such issues as consent, injunctive relief, and Rule 23 for mass-tort cases. Rob and his fellow panelists will examine the extent to which multi-national entities may seek to avoid Purdue Pharma through chapter 15.

For more information and to register, click below.